相似文献
1
New and developing therapies for atopic dermatitis.
An Bras Dermatol. 2018 Jan-Feb;93(1):104-107. doi: 10.1590/abd1806-4841.20187682.
2
[Current and upcoming treatments of adult atopic dermatitis].
Ann Dermatol Venereol. 2017 Dec;144 Suppl 5:VS29-VS37. doi: 10.1016/S0151-9638(18)30089-9.
3
New and emerging therapies for paediatric atopic dermatitis.
Lancet Child Adolesc Health. 2019 May;3(5):343-353. doi: 10.1016/S2352-4642(19)30030-6. Epub 2019 Mar 20.
4
Itch in Atopic Dermatitis Management.
Curr Probl Dermatol. 2016;50:86-93. doi: 10.1159/000446048. Epub 2016 Aug 23.
5
Systemic therapy of atopic dermatitis in children.
Drugs. 2009;69(3):297-306. doi: 10.2165/00003495-200969030-00005.
6
Health literacy and topical corticosteroid adherence in parents of children with atopic dermatitis in France.
J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1417-e1419. doi: 10.1111/jdv.19345. Epub 2023 Aug 1.
7
[Atopic dermatitis].
Ugeskr Laeger. 2018 Jan 22;180(4).
8
[Not Available].
Ann Dermatol Venereol. 2019 Dec;146(12S3):12S85-12S95. doi: 10.1016/S0151-9638(20)30018-1.
9
[Not Available].
Ann Dermatol Venereol. 2019 Dec;146(12S3):12S76-12S84. doi: 10.1016/S0151-9638(20)30017-X.
10
Use of an oral phosphodiesterase-4 inhibitor (apremilast) for the treatment of chronic, severe atopic dermatitis: a case report.
Dermatol Online J. 2017 May 15;23(5):13030/qt3588p0hn.
引用本文的文献
1
The Beneficial Roles of Seaweed in Atopic Dermatitis.
Mar Drugs. 2024 Dec 17;22(12):566. doi: 10.3390/md22120566.
2
[Not Available].
Glob Reg Health Technol Assess. 2024 Feb 16;11:38-50. doi: 10.33393/grhta.2024.2728. eCollection 2024 Jan-Dec.
3
Pterostilbene reduces the progression of atopic dermatitis via modulating inflammatory and oxidative stress biomarkers in mice.
Inflammopharmacology. 2023 Jun;31(3):1289-1303. doi: 10.1007/s10787-023-01214-z. Epub 2023 Apr 17.
4
Polymeric Nanoparticles as Tunable Nanocarriers for Targeted Delivery of Drugs to Skin Tissues for Treatment of Topical Skin Diseases.
Pharmaceutics. 2023 Feb 15;15(2):657. doi: 10.3390/pharmaceutics15020657.
5
[Not Available].
Glob Reg Health Technol Assess. 2020 Aug 24;7:57-65. doi: 10.33393/grhta.2020.710. eCollection 2020 Jan-Dec.
6
Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.
Acta Derm Venereol. 2022 Mar 22;102:adv00677. doi: 10.2340/actadv.v102.1088.
7
Osthole Inhibits Expression of Genes Associated with Toll-like Receptor 2 Signaling Pathway in an Organotypic 3D Skin Model of Human Epidermis with Atopic Dermatitis.
Cells. 2021 Dec 28;11(1):88. doi: 10.3390/cells11010088.
8
Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro.
Int J Mol Sci. 2021 Nov 5;22(21):12000. doi: 10.3390/ijms222112000.
9
Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information.
Front Immunol. 2021 Oct 13;12:724277. doi: 10.3389/fimmu.2021.724277. eCollection 2021.
10
Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies.
Pharmaceuticals (Basel). 2021 Aug 24;14(9):837. doi: 10.3390/ph14090837.
本文引用的文献
1
Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses.
J Am Acad Dermatol. 2017 Jul;77(1):177-180. doi: 10.1016/j.jaad.2017.03.020.
2
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
N Engl J Med. 2017 Mar 2;376(9):826-835. doi: 10.1056/NEJMoa1606490.
3
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30.
4
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.
Br J Dermatol. 2016 Nov;175(5):902-911. doi: 10.1111/bjd.14871. Epub 2016 Sep 24.
5
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
J Am Acad Dermatol. 2016 Sep;75(3):494-503.e6. doi: 10.1016/j.jaad.2016.05.046. Epub 2016 Jul 11.
6
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2. doi: 10.1016/j.jaad.2014.11.024. Epub 2015 Jan 13.
7
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
J Allergy Clin Immunol. 2014 Dec;134(6):1293-1300. doi: 10.1016/j.jaci.2014.10.013.
8
Application of moisturizer to neonates prevents development of atopic dermatitis.
J Allergy Clin Immunol. 2014 Oct;134(4):824-830.e6. doi: 10.1016/j.jaci.2014.07.060.
9
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention.
J Allergy Clin Immunol. 2014 Oct;134(4):818-23. doi: 10.1016/j.jaci.2014.08.005.
10
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768.
Zotero 插件